Mechanism of BLyS action in B cell immunity

被引:73
作者
Do, RKG
Chen-Kiang, S
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Cornell Rockefeller Sloan Kettering Tri Int MD Ph, New York, NY 10021 USA
关键词
autoimmunity; humoral immune response; apoptosis; TNF; NF-kappaB;
D O I
10.1016/S1359-6101(01)00025-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The B lymphocyte stimulator (BLyS), also known as BAFF, THANK, TALL-1 and zTNF4, is the most recent addition to the tumor necrosis factor family (TNF) ligands and has a unique role in B cell immunity. Its requirement for the humoral immune response is evident in mice lacking BlyS, which exhibit profound deficiencies in peripheral B cell development and maturation. It regulates the antibody response, as shown in mice overexpressing BLyS, which develop autoimmune manifestations resulting from peripheral B cell expansion and differentiation. Attenuation of apoptosis appears to underlie BLyS action in B cells. However, elucidation of the mechanism of BLyS has proven to be more challenging, because BLyS binds three different TNF receptors (TACI/BCMA/BAFF-R) and shares overlapping functions with a related TNF ligand, APRIL. The unique role of BLyS in B cell development and differentiation and the pathogenesis of autoimmune diseases, systemic lupus erythematosus (SLE) in particular, makes the study of BLyS and its downstream targets attractive in the development of novel therapies. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:19 / 25
页数:7
相关论文
共 53 条
  • [1] BAFF mediates survival of peripheral immature B lymphocytes
    Batten, M
    Groom, J
    Cachero, TG
    Qian, F
    Schneider, P
    Tschopp, J
    Browning, JL
    Mackay, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) : 1453 - 1465
  • [2] Nuclear factor κB is required for the development of marginal zone B lymphocytes
    Cariappa, A
    Liou, HC
    Horwitz, BH
    Pillai, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08) : 1175 - 1182
  • [3] Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
  • [4] 2-S
  • [5] Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control
    Chu, ZL
    McKinsey, TA
    Liu, L
    Gentry, JJ
    Malim, MH
    Ballard, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) : 10057 - 10062
  • [6] Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
    Do, RKG
    Hatada, E
    Lee, H
    Tourigny, MR
    Hilbert, D
    Chen-Kiang, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 953 - 964
  • [7] Foster MH, 1999, SEMIN NEPHROL, V19, P12
  • [8] TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
    Gross, JA
    Johnston, J
    Mudri, S
    Enselman, R
    Dillon, SR
    Madden, K
    Xu, WF
    Parrish-Novak, J
    Foster, D
    Lofton-Day, C
    Moore, M
    Littau, A
    Grossman, A
    Haugen, H
    Foley, K
    Blumberg, H
    Harrison, K
    Kindsvogel, W
    Clegg, CH
    [J]. NATURE, 2000, 404 (6781) : 995 - 999
  • [9] TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS
    Gross, JA
    Dillon, SR
    Mudri, S
    Johnston, J
    Littau, A
    Roque, R
    Rixon, M
    Schou, O
    Foley, KP
    Haugen, H
    McMillen, S
    Waggie, K
    Schreckhise, RW
    Shoemaker, K
    Vu, T
    Moore, M
    Grossman, A
    Clegg, CH
    [J]. IMMUNITY, 2001, 15 (02) : 289 - 302
  • [10] B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
    Grumont, RJ
    Rourke, IJ
    O'Reilly, LA
    Strasser, A
    Miyake, K
    Sha, W
    Gerondakis, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 663 - 674